首页 > 最新文献

Laparoscopic Endoscopic and Robotic Surgery最新文献

英文 中文
Robotic single-incision left hemihepatectomy for intrahepatic bile duct stones by Da Vinci single-site surgical system: A case report with video 机器人单切口左半肝切除术治疗肝内胆管结石:附视频1例
Q3 Medicine Pub Date : 2021-09-01 DOI: 10.1016/j.lers.2021.08.006
Xiao Liang , Junhao Zheng , Jiaqi Gao , Yubin Sheng , Tianyu Lin , Xiujun Cai

Minimally invasive surgery is a trend in hepatobiliary surgery. A 56-year-old female patient was admitted to our institution for intrahepatic lithiasis. The CT scan showed multiple calculi in the left liver, dilation of the left intrahepatic bile duct and liver atrophy of the left lobe. Robotic single-incision left hemihepatectomy by the single-site system was successfully applied. With the idea of enhanced recovery after surgery, the patient was discharged on the third day after the operation without any morbidity. Robotic single-incision surgery is more frequent in gynecologic and urological surgery. As far as we know, this is the first robotic single-incision left hemihepatectomy report in the world.

微创手术是肝胆外科的发展趋势。一名56岁女性患者因肝内结石入院。CT示左肝多发结石,左肝内胆管扩张,左叶肝萎缩。成功应用单部位机器人单切口左半肝切除术。本着促进术后恢复的理念,患者于术后第三天出院,无任何发病。机器人单切口手术在妇科和泌尿外科中较为常见。据我们所知,这是世界上第一个机器人单切口左半肝切除术的报道。
{"title":"Robotic single-incision left hemihepatectomy for intrahepatic bile duct stones by Da Vinci single-site surgical system: A case report with video","authors":"Xiao Liang ,&nbsp;Junhao Zheng ,&nbsp;Jiaqi Gao ,&nbsp;Yubin Sheng ,&nbsp;Tianyu Lin ,&nbsp;Xiujun Cai","doi":"10.1016/j.lers.2021.08.006","DOIUrl":"10.1016/j.lers.2021.08.006","url":null,"abstract":"<div><p>Minimally invasive surgery is a trend in hepatobiliary surgery. A 56-year-old female patient was admitted to our institution for intrahepatic lithiasis. The CT scan showed multiple calculi in the left liver, dilation of the left intrahepatic bile duct and liver atrophy of the left lobe. Robotic single-incision left hemihepatectomy by the single-site system was successfully applied. With the idea of enhanced recovery after surgery, the patient was discharged on the third day after the operation without any morbidity. Robotic single-incision surgery is more frequent in gynecologic and urological surgery. As far as we know, this is the first robotic single-incision left hemihepatectomy report in the world.</p></div>","PeriodicalId":32893,"journal":{"name":"Laparoscopic Endoscopic and Robotic Surgery","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.lers.2021.08.006","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84715786","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Modified McKeown minimally invasive esophagectomy for esophageal cancer: A retrospective study of 376 patients at a single institution 改良McKeown微创食管切除术治疗食管癌:一项对同一机构376例患者的回顾性研究
Q3 Medicine Pub Date : 2021-09-01 DOI: 10.1016/j.lers.2021.08.004
Ziyi Zhu, Raojun Luo, Zhengfu He, Yong Xu, Shaohua Xu, Peijian Yan

Objective

Minimally invasive esophagectomy (MIE) was first implemented in 1992 and various MIEs have been performed subsequently. The modified McKeown MIE that includes thoracoscopic and laparoscopic procedures with left neck anastomosis has been implemented in our institution since 2006. We herein report our first 5-year experience in 376 consecutive patients undergone the modified McKeown MIE for esophageal cancer to evaluate perioperative outcomes and survival.

Methods

A total of 376 patients underwent a modified McKeown MIE from March 2016 to March 2021 at Sir Run Run Shaw Hospital, Zhejiang University School of Medicine. Patient demographics and perioperative outcomes were collected and assessed, and overall survival and disease-free survival were analyzed.

Results

All procedures were completed successfully with no conversions to open surgery. The median operative time was 240 min, and the median blood loss was 100 mL. The median number of harvested lymph nodes was 29, the median number of harvested thoracic lymph nodes was 18, and of harvested abdominal nodes was 10. The 30-day mortality rate was 0.27% and complications occurred in 133 (35.4%) patients. The median follow-up period was 19 (1–60) months, and 244 patients completed more than 1 year of follow-up. The 1-year overall survival and disease-free survival were 79.5% and 73.8%, respectively.

Conclusion

The modified McKeown MIE is safe and feasible for esophageal cancer, offering satisfactory perioperative outcomes and acceptable oncologic survival.

目的微创食管切除术(MIE)于1992年首次实施,随后进行了多种微创食管切除术。改良的McKeown MIE,包括胸腔镜和腹腔镜手术,左颈吻合,自2006年以来在我机构实施。在此,我们报告了376例连续接受改良McKeown MIE治疗食管癌的患者的第一个5年经验,以评估围手术期预后和生存率。方法2016年3月至2021年3月在浙江大学医学院邵逸夫医院接受改良McKeown MIE治疗的376例患者。收集和评估患者人口统计学和围手术期结果,并分析总生存期和无病生存期。结果所有手术均顺利完成,无中转开腹手术。手术时间中位数为240 min,出血量中位数为100 mL。淋巴结清扫清扫中位数为29个,胸淋巴结清扫中位数为18个,腹淋巴结清扫中位数为10个。30天死亡率为0.27%,并发症133例(35.4%)。中位随访期为19(1 - 60)个月,244例患者完成了1年以上的随访。1年总生存率和无病生存率分别为79.5%和73.8%。结论改良McKeown MIE治疗食管癌安全可行,围手术期疗效满意,肿瘤生存率较高。
{"title":"Modified McKeown minimally invasive esophagectomy for esophageal cancer: A retrospective study of 376 patients at a single institution","authors":"Ziyi Zhu,&nbsp;Raojun Luo,&nbsp;Zhengfu He,&nbsp;Yong Xu,&nbsp;Shaohua Xu,&nbsp;Peijian Yan","doi":"10.1016/j.lers.2021.08.004","DOIUrl":"10.1016/j.lers.2021.08.004","url":null,"abstract":"<div><h3>Objective</h3><p>Minimally invasive esophagectomy (MIE) was first implemented in 1992 and various MIEs have been performed subsequently. The modified McKeown MIE that includes thoracoscopic and laparoscopic procedures with left neck anastomosis has been implemented in our institution since 2006. We herein report our first 5-year experience in 376 consecutive patients undergone the modified McKeown MIE for esophageal cancer to evaluate perioperative outcomes and survival.</p></div><div><h3>Methods</h3><p>A total of 376 patients underwent a modified McKeown MIE from March 2016 to March 2021 at Sir Run Run Shaw Hospital, Zhejiang University School of Medicine. Patient demographics and perioperative outcomes were collected and assessed, and overall survival and disease-free survival were analyzed.</p></div><div><h3>Results</h3><p>All procedures were completed successfully with no conversions to open surgery. The median operative time was 240 min, and the median blood loss was 100 mL. The median number of harvested lymph nodes was 29, the median number of harvested thoracic lymph nodes was 18, and of harvested abdominal nodes was 10. The 30-day mortality rate was 0.27% and complications occurred in 133 (35.4%) patients. The median follow-up period was 19 (1–60) months, and 244 patients completed more than 1 year of follow-up. The 1-year overall survival and disease-free survival were 79.5% and 73.8%, respectively.</p></div><div><h3>Conclusion</h3><p>The modified McKeown MIE is safe and feasible for esophageal cancer, offering satisfactory perioperative outcomes and acceptable oncologic survival.</p></div>","PeriodicalId":32893,"journal":{"name":"Laparoscopic Endoscopic and Robotic Surgery","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.lers.2021.08.004","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85304348","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Commentary on impact of pulmonary function on robotic pulmonary resection 肺功能对机器人肺切除术的影响
Q3 Medicine Pub Date : 2021-09-01 DOI: 10.1016/j.lers.2021.05.003
Anthony Le , Matheus Carelli , Allen Guo , Christopher Cao
{"title":"Commentary on impact of pulmonary function on robotic pulmonary resection","authors":"Anthony Le ,&nbsp;Matheus Carelli ,&nbsp;Allen Guo ,&nbsp;Christopher Cao","doi":"10.1016/j.lers.2021.05.003","DOIUrl":"10.1016/j.lers.2021.05.003","url":null,"abstract":"","PeriodicalId":32893,"journal":{"name":"Laparoscopic Endoscopic and Robotic Surgery","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.lers.2021.05.003","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77220824","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Current status of minimally invasive surgery for pancreatic cancer 胰腺癌微创手术的现状
Q3 Medicine Pub Date : 2021-09-01 DOI: 10.1016/j.lers.2021.08.003
Wenhao Luo , Taiping Zhang

Pancreatic cancer (PC) is the most lethal cancer among digestive system cancers. Although the only way to radically cure PC is surgical resection, complex surgical procedures and severe post-operative complications lead to high mortality. In recent years, minimally invasive surgery has become more common for PC. Minimally invasive pancreatic resection (MIPR) with the laparoscopic or robotic method has shown its superiority compared with traditional surgery. However, increasing evidence indicates that the long-term or even short-term outcomes of MIPR for PC patients remain controversial. Moreover, the indications and learning curve of MIPR require further assessment. This review aims to discuss the progress in current MIPR, analyze the specific problems and obstacles in the development of MIPR, and try to standardize MIPR procedures and improve the outcomes of MIPR.

胰腺癌(PC)是消化道癌症中最致命的癌症。虽然根治PC的唯一途径是手术切除,但复杂的手术程序和严重的术后并发症导致高死亡率。近年来,微创手术治疗PC越来越普遍。与传统手术相比,腹腔镜或机器人微创胰腺切除术(MIPR)已显示出其优越性。然而,越来越多的证据表明,MIPR对PC患者的长期甚至短期结果仍存在争议。此外,MIPR的适应症和学习曲线需要进一步评估。本文旨在探讨当前MIPR的进展,分析MIPR发展中存在的具体问题和障碍,以期规范MIPR的程序,提高MIPR的效果。
{"title":"Current status of minimally invasive surgery for pancreatic cancer","authors":"Wenhao Luo ,&nbsp;Taiping Zhang","doi":"10.1016/j.lers.2021.08.003","DOIUrl":"10.1016/j.lers.2021.08.003","url":null,"abstract":"<div><p>Pancreatic cancer (PC) is the most lethal cancer among digestive system cancers. Although the only way to radically cure PC is surgical resection, complex surgical procedures and severe post-operative complications lead to high mortality. In recent years, minimally invasive surgery has become more common for PC. Minimally invasive pancreatic resection (MIPR) with the laparoscopic or robotic method has shown its superiority compared with traditional surgery. However, increasing evidence indicates that the long-term or even short-term outcomes of MIPR for PC patients remain controversial. Moreover, the indications and learning curve of MIPR require further assessment. This review aims to discuss the progress in current MIPR, analyze the specific problems and obstacles in the development of MIPR, and try to standardize MIPR procedures and improve the outcomes of MIPR.</p></div>","PeriodicalId":32893,"journal":{"name":"Laparoscopic Endoscopic and Robotic Surgery","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.lers.2021.08.003","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73779688","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Use of the ulcerative colitis endoscopic index of severity and Mayo endoscopic score for predicting the therapeutic effect of mesalazine in patients with ulcerative colitis 应用溃疡性结肠炎内镜严重程度指数和Mayo内镜评分预测美沙拉嗪对溃疡性结肠炎患者的治疗效果
Q3 Medicine Pub Date : 2021-06-01 DOI: 10.1016/j.lers.2021.04.003
Haotian Chen , Lexi Wu , Mengyu Wang , Bule Shao , Lingna Ye , Yu Zhang , Qian Cao

Objective

The ulcerative colitis endoscopic index of severity (UCEIS) and the Mayo endoscopic score (MES) are developed as objective methods of evaluating endoscopic severity in patients with ulcerative colitis (UC). The aim of this study is to investigate the diagnostic accuracy of the UCEIS and MES in predicting the patient's response to mesalazine.

Methods

Consecutive patients with UC who had undergone colonoscopy within 1 month before starting mesalazine between October 2011 and July 2016 were retrospectively collected at the Department of Gastroenterology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine. The median follow-up was 81 months, and all the data were analyzed in January 2021. The primary outcome was the need for step-up treatment, which included the use of corticosteroids, immunomodulatory, or surgery during admission and follow-up. Data were analyzed using the χ2 or Fisher exact test, Spearman test, t-test, and Mann–Whitney U test.

Results

Totally, 65 patients were enrolled, of whom 12 (18.5%) needed step-up treatment due to nonresponse to mesalazine. The UCEIS score, MES, and the ulcerative colitis disease activity index (UCDAI) score were significantly higher in patients who had nonresponse to mesalazine (UCEIS score: 6.92 ± 0.69 vs. 4.45 ± 1.17, p < 0.001; MES: 2.67 ± 0.49 vs. 2.15 ± 0.69, p = 0.024; UCDAI score: 9.33 ± 1.87 vs. 6.70 ± 2.38, p = 0.002). In the multivariate analysis, the UCEIS score (OR = 25.65, 95% CI: 3.048–45.985, p = 0.003), UCDAI score (OR = 1.605, 95% CI: 1.144–2.254, p = 0.006), and C-reactive protein level (OR = 1.056, 95% CI: 1.006–1.108, p = 0.026) were independent risk factors of nonresponse. The area under the ROC curve of UCEIS was 0.95, with a sensitivity of 100% and specificity of 84.6%, a cut-off value of 6, which outperformed the MES with an area under the ROC curve of 0.70. When the UCEIS score ≥6, 60% of patients eventually needed step-up treatment.

Conclusions

The UCEIS is a useful instrument for predicting the therapeutic effect in patients with UC treated with mesalazine. The high probability of mesalazine treatment failure and benefits of other therapies should be discussed in patients with baseline UCEIS score ≥6.

目的建立溃疡性结肠炎内镜严重程度指数(UCEIS)和Mayo内镜评分(MES),作为评估溃疡性结肠炎(UC)患者内镜严重程度的客观方法。本研究的目的是探讨UCEIS和MES在预测患者对美沙拉嗪的反应方面的诊断准确性。方法回顾性收集2011年10月至2016年7月浙江大学医学院邵逸夫医院消化内科1个月内连续行结肠镜检查的UC患者。中位随访81个月,所有数据于2021年1月进行分析。主要结局是需要加强治疗,包括在入院和随访期间使用皮质类固醇、免疫调节剂或手术。数据分析采用χ2或Fisher精确检验、Spearman检验、t检验和Mann-Whitney U检验。结果共纳入65例患者,其中12例(18.5%)因对美沙拉嗪无反应需要加强治疗。美沙拉嗪无反应患者的UCEIS评分、MES和溃疡性结肠炎疾病活动指数(UCDAI)评分均显著高于对照组(UCEIS评分:6.92±0.69比4.45±1.17,p <0.001;MES: 2.67±0.49 vs. 2.15±0.69,p = 0.024;UCDAI得分:9.33±1.87和6.70±2.38,p = 0.002)。在多因素分析中,UCEIS评分(OR = 25.65, 95% CI: 3.048 ~ 45.985, p = 0.003)、UCDAI评分(OR = 1.605, 95% CI: 1.144 ~ 2.254, p = 0.006)和c反应蛋白水平(OR = 1.056, 95% CI: 1.006 ~ 1.108, p = 0.026)是无反应的独立危险因素。UCEIS的ROC曲线下面积为0.95,灵敏度为100%,特异性为84.6%,截断值为6,优于MES的ROC曲线下面积为0.70。当UCEIS评分≥6时,60%的患者最终需要加强治疗。结论UCEIS是预测美沙拉嗪治疗UC疗效的有效工具。对于基线UCEIS评分≥6的患者,应讨论美萨拉嗪治疗失败的高概率和其他治疗的益处。
{"title":"Use of the ulcerative colitis endoscopic index of severity and Mayo endoscopic score for predicting the therapeutic effect of mesalazine in patients with ulcerative colitis","authors":"Haotian Chen ,&nbsp;Lexi Wu ,&nbsp;Mengyu Wang ,&nbsp;Bule Shao ,&nbsp;Lingna Ye ,&nbsp;Yu Zhang ,&nbsp;Qian Cao","doi":"10.1016/j.lers.2021.04.003","DOIUrl":"10.1016/j.lers.2021.04.003","url":null,"abstract":"<div><h3>Objective</h3><p>The ulcerative colitis endoscopic index of severity (UCEIS) and the Mayo endoscopic score (MES) are developed as objective methods of evaluating endoscopic severity in patients with ulcerative colitis (UC). The aim of this study is to investigate the diagnostic accuracy of the UCEIS and MES in predicting the patient's response to mesalazine.</p></div><div><h3>Methods</h3><p>Consecutive patients with UC who had undergone colonoscopy within 1 month before starting mesalazine between October 2011 and July 2016 were retrospectively collected at the Department of Gastroenterology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine. The median follow-up was 81 months, and all the data were analyzed in January 2021. The primary outcome was the need for step-up treatment, which included the use of corticosteroids, immunomodulatory, or surgery during admission and follow-up. Data were analyzed using the χ<sup>2</sup> or Fisher exact test, Spearman test, <em>t</em>-test, and Mann–Whitney <em>U</em> test.</p></div><div><h3>Results</h3><p>Totally, 65 patients were enrolled, of whom 12 (18.5%) needed step-up treatment due to nonresponse to mesalazine. The UCEIS score, MES, and the ulcerative colitis disease activity index (UCDAI) score were significantly higher in patients who had nonresponse to mesalazine (UCEIS score: 6.92 ± 0.69 vs. 4.45 ± 1.17, <em>p</em> &lt; 0.001; MES: 2.67 ± 0.49 vs. 2.15 ± 0.69, <em>p</em> = 0.024; UCDAI score: 9.33 ± 1.87 vs. 6.70 ± 2.38, <em>p</em> = 0.002). In the multivariate analysis, the UCEIS score (OR = 25.65, 95% CI: 3.048–45.985, <em>p</em> = 0.003), UCDAI score (OR = 1.605, 95% CI: 1.144–2.254, <em>p</em> = 0.006), and C-reactive protein level (OR = 1.056, 95% CI: 1.006–1.108, <em>p</em> = 0.026) were independent risk factors of nonresponse. The area under the ROC curve of UCEIS was 0.95, with a sensitivity of 100% and specificity of 84.6%, a cut-off value of 6, which outperformed the MES with an area under the ROC curve of 0.70. When the UCEIS score ≥6, 60% of patients eventually needed step-up treatment.</p></div><div><h3>Conclusions</h3><p>The UCEIS is a useful instrument for predicting the therapeutic effect in patients with UC treated with mesalazine. The high probability of mesalazine treatment failure and benefits of other therapies should be discussed in patients with baseline UCEIS score ≥6.</p></div>","PeriodicalId":32893,"journal":{"name":"Laparoscopic Endoscopic and Robotic Surgery","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.lers.2021.04.003","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"76381071","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Two arms-three instruments robot-assisted laparoscopic hysterectomy: A reproducible technique 双臂三仪器机器人辅助腹腔镜子宫切除术:一项可重复的技术
Q3 Medicine Pub Date : 2021-06-01 DOI: 10.1016/j.lers.2021.05.002
Rooma Sinha, Bana Rupa, Girija Shankar Mohanty

Although laparoscopic hysterectomy has been used for more than 3 decades, it is not universally adopted due to steep learning curve. The robotic platform can bridge this gap and reduce the need for open hysterectomy with enhanced dexterity and accurate depth perception by 3D vision and wristed intuitive movements. This technical note introduces a two arms-three instruments “Sinha-Apollo technique” for da Vinci Si system for performing robotic-assisted laparoscopic hysterectomy in simplified and reproducible steps.

虽然腹腔镜子宫切除术已经使用了30多年,但由于学习曲线陡峭,并没有被普遍采用。机器人平台可以弥补这一差距,并通过3D视觉和腕部直观运动增强灵活性和准确的深度感知,减少对开放式子宫切除术的需求。本技术说明介绍了一种用于达芬奇Si系统的两臂三仪器“Sinha-Apollo技术”,用于以简化和可重复的步骤进行机器人辅助腹腔镜子宫切除术。
{"title":"Two arms-three instruments robot-assisted laparoscopic hysterectomy: A reproducible technique","authors":"Rooma Sinha,&nbsp;Bana Rupa,&nbsp;Girija Shankar Mohanty","doi":"10.1016/j.lers.2021.05.002","DOIUrl":"10.1016/j.lers.2021.05.002","url":null,"abstract":"<div><p>Although laparoscopic hysterectomy has been used for more than 3 decades, it is not universally adopted due to steep learning curve. The robotic platform can bridge this gap and reduce the need for open hysterectomy with enhanced dexterity and accurate depth perception by 3D vision and wristed intuitive movements. This technical note introduces a two arms-three instruments “Sinha-Apollo technique” for da Vinci Si system for performing robotic-assisted laparoscopic hysterectomy in simplified and reproducible steps.</p></div>","PeriodicalId":32893,"journal":{"name":"Laparoscopic Endoscopic and Robotic Surgery","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.lers.2021.05.002","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85121846","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Transoral endoscopic excision of a giant parapharyngeal space tumour: A case report 经口内镜切除巨大咽旁间隙肿瘤1例
Q3 Medicine Pub Date : 2021-06-01 DOI: 10.1016/j.lers.2021.02.001
Yazid Bin Pol Ong, Liew Yew Toong, Sakina Binti Gauth, Prepageran Narayanan

Most of the parapharyngeal space tumours are benign. The primary treatment is complete resection of the tumour. Due to its location in the deep neck space, a pre-styloid tumour can be resected via the transoral approach. However, the surgical field is limited by the small oral cavity. With the use of rigid endoscopes, removing benign tumours through transoral approach in the parapharyngeal space is possible as they provide a broad and enlarged view of the confined space. Here, we report a case of a 64-year-old male with a giant pre-styloid parapharyngeal space tumour, who successfully underwent transoral endoscopic excision. Postoperatively, the patient had short hospital stay of total 3 days. His chewing and swallowing were not affected, and he resumed oral feeding prior to discharge.

大多数咽旁间隙肿瘤是良性的。主要的治疗方法是完全切除肿瘤。由于位于深颈部,茎突前肿瘤可经口入路切除。然而,手术范围受限于小口腔。使用刚性内窥镜,通过经口入路在咽旁间隙切除良性肿瘤是可能的,因为它们提供了狭窄空间的广阔和扩大的视野。在此,我们报告一位64岁男性,患有巨大的茎突前咽间隙肿瘤,他成功地接受了经口内镜切除。术后患者住院时间短,共3天。他的咀嚼和吞咽未受影响,出院前恢复口服喂养。
{"title":"Transoral endoscopic excision of a giant parapharyngeal space tumour: A case report","authors":"Yazid Bin Pol Ong,&nbsp;Liew Yew Toong,&nbsp;Sakina Binti Gauth,&nbsp;Prepageran Narayanan","doi":"10.1016/j.lers.2021.02.001","DOIUrl":"10.1016/j.lers.2021.02.001","url":null,"abstract":"<div><p>Most of the parapharyngeal space tumours are benign. The primary treatment is complete resection of the tumour. Due to its location in the deep neck space, a pre-styloid tumour can be resected via the transoral approach. However, the surgical field is limited by the small oral cavity. With the use of rigid endoscopes, removing benign tumours through transoral approach in the parapharyngeal space is possible as they provide a broad and enlarged view of the confined space. Here, we report a case of a 64-year-old male with a giant pre-styloid parapharyngeal space tumour, who successfully underwent transoral endoscopic excision. Postoperatively, the patient had short hospital stay of total 3 days. His chewing and swallowing were not affected, and he resumed oral feeding prior to discharge.</p></div>","PeriodicalId":32893,"journal":{"name":"Laparoscopic Endoscopic and Robotic Surgery","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.lers.2021.02.001","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"89740896","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Effect of body mass index on the operation time and postoperative hospital stay of retroperitoneal laparoscopic renal cyst decortication 体重指数对后腹腔镜肾囊肿去皮术时间及术后住院时间的影响
Q3 Medicine Pub Date : 2021-06-01 DOI: 10.1016/j.lers.2021.05.001
Peng Gu , Meilin Li , Minhao Zhang , Xiaoliang He

Objective

To investigate the effect of body mass index (BMI) on the operation time and postoperative hospital stay for patients who underwent retroperitoneal laparoscopic decortication for a single simple renal cyst.

Methods

A retrospective cohort study was conducted among 81 patients with single simple renal cyst who had undergone retroperitoneal laparoscopic cyst decortication from January 2017 to December 2019 in Wuxi Xishan People's Hospital. All patients were divided into three groups according to BMI: normal group (BMI<25 kg/m2, n = 44), overweight group (BMI = 25–30 kg/m2, n = 21), and obese group (BMI>30 kg/m2, n = 16). Multiple linear regression was conducted to investigate the correlation.

Results

The three groups were comparable in terms of age, gender, maximum diameter of cyst, and cyst location. In the aspect of operation time, only the patients in obese group had longer duration when compared with those in the normal group (59.1 ± 15.7 min vs. 45.2 ± 12.8 min, p = 0.001). And the patients in the obese group had significantly longer hospital stay compared with those in the normal group (6.2 ± 1.9 d vs. 5.2 ± 0.5 d, p = 0.002) and overweight group (6.2 ± 1.9 d vs. 5.0 ± 1.0 d, p = 0.001). In the analysis of multiple linear regression, it was found that operation time is significantly affected by BMI and location 2, with coefficients of 1.299 and −8.646 respectively. The influence of BMI was greater than location 2 (0.335 vs. −0.289). For hospital stay, only BMI had an effect on it, with a coefficient of 0.110.

Conclusion

BMI was a major factor that associated with longer operation time and hospital stay in patients with retroperitoneal laparoscopic renal cyst decortication.

目的探讨体重指数(BMI)对单纯性肾囊肿经腹膜后腹腔镜去皮术患者手术时间及术后住院时间的影响。方法对2017年1月至2019年12月在无锡市西山人民医院行后腹腔镜囊肿去皮术的81例单纯性肾囊肿患者进行回顾性队列研究。所有患者根据BMI分为正常组(BMI = 25 kg/m2, n = 44)、超重组(BMI = 25 ~ 30 kg/m2, n = 21)、肥胖组(BMI = 30 kg/m2, n = 16)。采用多元线性回归分析其相关性。结果三组患者在年龄、性别、囊肿最大直径、囊肿位置等方面具有可比性。在手术时间方面,只有肥胖组患者手术时间较正常组更长(59.1±15.7 min vs. 45.2±12.8 min, p = 0.001)。肥胖组患者住院时间明显长于正常组(6.2±1.9 d比5.2±0.5 d, p = 0.002)和超重组(6.2±1.9 d比5.0±1.0 d, p = 0.001)。在多元线性回归分析中发现,BMI和位置2对手术时间有显著影响,其系数分别为1.299和- 8.646。BMI的影响大于位置2 (0.335 vs. - 0.289)。对于住院时间,只有BMI对其有影响,系数为0.110。结论bmi是导致后腹腔镜肾囊肿去皮术患者手术时间和住院时间延长的主要因素。
{"title":"Effect of body mass index on the operation time and postoperative hospital stay of retroperitoneal laparoscopic renal cyst decortication","authors":"Peng Gu ,&nbsp;Meilin Li ,&nbsp;Minhao Zhang ,&nbsp;Xiaoliang He","doi":"10.1016/j.lers.2021.05.001","DOIUrl":"10.1016/j.lers.2021.05.001","url":null,"abstract":"<div><h3>Objective</h3><p>To investigate the effect of body mass index (BMI) on the operation time and postoperative hospital stay for patients who underwent retroperitoneal laparoscopic decortication for a single simple renal cyst.</p></div><div><h3>Methods</h3><p>A retrospective cohort study was conducted among 81 patients with single simple renal cyst who had undergone retroperitoneal laparoscopic cyst decortication from January 2017 to December 2019 in Wuxi Xishan People's Hospital. All patients were divided into three groups according to BMI: normal group (BMI&lt;25 kg/m<sup>2</sup>, <em>n</em> = 44), overweight group (BMI = 25–30 kg/m<sup>2</sup>, <em>n</em> = 21), and obese group (BMI&gt;30 kg/m<sup>2</sup>, <em>n</em> = 16). Multiple linear regression was conducted to investigate the correlation.</p></div><div><h3>Results</h3><p>The three groups were comparable in terms of age, gender, maximum diameter of cyst, and cyst location. In the aspect of operation time, only the patients in obese group had longer duration when compared with those in the normal group (59.1 ± 15.7 min vs. 45.2 ± 12.8 min, <em>p</em> = 0.001). And the patients in the obese group had significantly longer hospital stay compared with those in the normal group (6.2 ± 1.9 d vs. 5.2 ± 0.5 d, <em>p</em> = 0.002) and overweight group (6.2 ± 1.9 d vs. 5.0 ± 1.0 d, <em>p</em> = 0.001). In the analysis of multiple linear regression, it was found that operation time is significantly affected by BMI and location 2, with coefficients of 1.299 and −8.646 respectively. The influence of BMI was greater than location 2 (0.335 vs. −0.289). For hospital stay, only BMI had an effect on it, with a coefficient of 0.110.</p></div><div><h3>Conclusion</h3><p>BMI was a major factor that associated with longer operation time and hospital stay in patients with retroperitoneal laparoscopic renal cyst decortication.</p></div>","PeriodicalId":32893,"journal":{"name":"Laparoscopic Endoscopic and Robotic Surgery","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.lers.2021.05.001","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87578758","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Application of extracorporeal membrane oxygenation in the endoscopic treatment of severe benign airway stenosis: A case report and literature review 体外膜氧合在内镜下治疗严重良性气道狭窄中的应用:1例报告并文献复习
Q3 Medicine Pub Date : 2021-06-01 DOI: 10.1016/j.lers.2021.04.002
Yuyuan Liang , Jihong Zhu , Xing Zheng , Qing Qiao , Yaolin Guan , Jisong Zhang , Enguo Chen

Ventilation strategies in patients with severe tracheal stenosis should be tailored to the patient according to the underlying cause and narrowing location. This report is on a case of a 68-year-old male patient, who was admitted for radiotherapy because of esophageal cancer and then developed severe stenosis at the cervical trachea. We used venovenous extracorporeal membrane oxygenation to secure the airway and ensure adequate oxygenation. Then urgent endoscopic balloon dilation of airway stenosis was successfully performed under general anesthesia. This case shows that venovenous extracorporeal membrane oxygenation can be used in endoscopic tracheal procedures for patients with severe benign stenosis in the upper-trachea who are unable to tolerate conventional ventilation.

严重气管狭窄患者的通气策略应根据病因和狭窄部位为患者量身定制。本文报告一例68岁男性患者,因食管癌入院接受放射治疗,后颈部气管严重狭窄。我们使用静脉-静脉体外膜氧合来保护气道并确保充足的氧合。然后在全麻下成功行气道狭窄急诊内镜球囊扩张术。本病例表明,静脉-静脉体外膜氧合可用于内镜气管手术,用于气管上部严重良性狭窄,不能耐受常规通气的患者。
{"title":"Application of extracorporeal membrane oxygenation in the endoscopic treatment of severe benign airway stenosis: A case report and literature review","authors":"Yuyuan Liang ,&nbsp;Jihong Zhu ,&nbsp;Xing Zheng ,&nbsp;Qing Qiao ,&nbsp;Yaolin Guan ,&nbsp;Jisong Zhang ,&nbsp;Enguo Chen","doi":"10.1016/j.lers.2021.04.002","DOIUrl":"10.1016/j.lers.2021.04.002","url":null,"abstract":"<div><p>Ventilation strategies in patients with severe tracheal stenosis should be tailored to the patient according to the underlying cause and narrowing location. This report is on a case of a 68-year-old male patient, who was admitted for radiotherapy because of esophageal cancer and then developed severe stenosis at the cervical trachea. We used venovenous extracorporeal membrane oxygenation to secure the airway and ensure adequate oxygenation. Then urgent endoscopic balloon dilation of airway stenosis was successfully performed under general anesthesia. This case shows that venovenous extracorporeal membrane oxygenation can be used in endoscopic tracheal procedures for patients with severe benign stenosis in the upper-trachea who are unable to tolerate conventional ventilation.</p></div>","PeriodicalId":32893,"journal":{"name":"Laparoscopic Endoscopic and Robotic Surgery","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.lers.2021.04.002","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78157059","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Acknowledgement to reviewers of Laparoscopic, Endoscopic and Robotic Surgery in 2020 感谢2020年腹腔镜、内窥镜和机器人手术的审稿人
Q3 Medicine Pub Date : 2021-03-01 DOI: 10.1016/j.lers.2021.01.003
{"title":"Acknowledgement to reviewers of Laparoscopic, Endoscopic and Robotic Surgery in 2020","authors":"","doi":"10.1016/j.lers.2021.01.003","DOIUrl":"10.1016/j.lers.2021.01.003","url":null,"abstract":"","PeriodicalId":32893,"journal":{"name":"Laparoscopic Endoscopic and Robotic Surgery","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.lers.2021.01.003","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88391119","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Laparoscopic Endoscopic and Robotic Surgery
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1